新加坡银行每月快讯 – 如释重负,度过困难时刻

摘要

  • 尽管美联储在3月总共降息150个基点,但本地利率正出现短期反弹。NIMs(净息差)全年可能会压缩到中期水平,低于先前的预期。
  • 2月贷款同比增长稳定在0.5%。随着COVID-19疫情接踵而至,在企业面临流动性紧缩的态势下,政府采取各种措施鼓励放贷,贷款将可能会维持在当前的增长水平。
  • 由于市场波动性处于2008年全球金融危机以来的最高月度水平,3月份的衍生品交易量同比增长34%。
  • 对新加坡银行业维持增持评级。本地银行将受益于政府推出的一系列措施,这些措施旨在通过风险分担和提供低成本融资,来减轻金融体系的压力。

 
 

暂缓本地贷款利率
尽管美联储在3月份出人意料地实施了两次降息150个基点,但我们观察到,本地利率显示出抵制降息的迹象。较2月的峰值,3M-SIBOR下跌73个基点,而3M-SOR 则下跌逾120个基点,之后反弹约50个基点至当前水平。贷款利率的稳定将用于判断本地银行对抵御NIM压缩压力的能力有多强。
NIM压缩的滞后效应,意味着利率下降所带来的全面影响,应该要到2020下半年才能体验到。因此,我们预计三家本地银行的全年NIM 将降至中期水平,低于此前预期的20个基点以上。 
HIBOR从低点反弹

与SIBOR类似,出现反弹,自3月双降息后,1M和3M-HIBOR也从低点反弹至略低于2%的水平,比2月份观察到的平均水平低20个基点左右。

贷款增长企稳

2月国内贷款同比增长了3.05%,自2019年11月以来,同比增长率保持稳定。随着经济正面临COVID-19爆发而出现的逆风,MAS(金管局)采取了一系列的规管和监管调控,以鼓励和支持金融机构的借贷活动,贷款增长可能会得到提振,并达到我们预测的全年增长2-3%的上限。

然而,预计整个行业的贷款重组 – 包括延长贷款期限和降低利率。重组将不会影响津贴,但推迟支付利息可能会在短期内导致银行的现金流减少。

有关MAS为支持金融机构贷款活动而发布的一系列公告的详情,请参阅附录A和附录B。

衍生品成交量将受益于波动性加剧

The VIX index(波动率指数)录得3月的月度均值为82.06点,为2008年全球金融危机以来的最高水平。新交所的DDAV在3月份同比跃升34%,2020年三季度,新交所的衍生品交易量在这3个月里面,每月分别录得23%, 11% 和34%。

波动性加剧导致的市场抛售,也看到出现大规模资金流向股市。SDAV在3月增长翻了一倍(同比增长114%),也达到了2008年全球金融危机以来的最高水平。 SDAV 在3月这个季度同比增长了114%。

SDAV和DDAV的改善,可能会使截至3月份本季度的收益将比我们的预期高出25%。

投资行动
对新加坡银行业维持增持评级。随着MAS货币政策的介入,以减少COVID-19大流行对经济的影响,本地银行将在一定程度上减轻其对金融体系带来的负担。随着贷款偿还的推迟,短期的流动性可能会受到影响,但政府的风险分担将使银行能够缓解资产质量风险,而政府提供的低成本资金,将使银行有能力在疫情结束后,长期支持贷款收益。

 
如果有想了解更多全球股市资讯,请关注微信公众号 “辉立资本新加坡” (SGPSPL)
同时提供在线免费开设股票账户,一个账户轻松交易全球股票和ETF美股,港股,新加坡股,中国A股,越南股票,韩国股票,德国股票,马来西亚股票,泰国股票,印尼股票,菲律宾股票,日本股票,澳大利亚股票,台湾股票,加拿大股票,英国股票,法国股票,荷兰股票,葡萄牙股票,比利时股票,土耳其股票如果本文是英文翻译版本,一切请以英文为准

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com